摘要
目的探讨黄芪注射液联合曲美他嗪片对病毒性心肌炎的临床诊治效果，为临床治疗病毒性心肌炎提供参考依据。方法回顾性分析本院2010年2月～2012年2月收治的病毒性心肌炎患者的临床资料，随机选取80例患者，按照治疗方法分为观察组（40例）与对照组（40例），在常规治理的基础上对照组给予曲美他嗪片进行治疗，观察组再加用黄芪注射液进行治疗。治疗结束后比较两组患者的治疗效果以及各项实验室指标。结果经过两个疗程的治疗，治疗后两组患者心肌酶谱检查结果比较，差异有统计学意义（P〈0．05），观察组优于对照组；在有效率方面比较观察组优于对照组，差异有统计学意义（P〈0．05）。结论在常规治疗的基础上给予黄芪注射液联合曲美他嗪片治疗病毒性心肌炎效果显著，不良反应小，值得临床推广应用。
Objective To investigate the clinical diagnosis and treatment of viral myocarditis, for the treatment of viral myocarditis with reference. Methods A retrospective analysis in our hospital from 2010 February to February 2012 year admits to viral myoearditis in patients with clinical data, randomly selected 80 patients, in accordance with the treatment method was divided into observation group （40 cases） and control group （40 cases）, in the conventional treat- ment on the basis of the control group was given Qumei trimetazidine tablets for treatment, observation group coupled with astragalus injection for treatment of. After the end of treatment between the two groups therapeutic effects and in- dexes were compared. Results After two courses of treatment, the patients with myocardial enzyme spectrum examina- tion results there was significant difference （P 〈 0.05）, the observation group was better than the control group; the effi- ciency had significant difference, the observation group was better than the control group. Conclusion Based on regu- lar treatment given the effect of Astragalus injection combined with trimetazidine Qnmei tablets in the treatment of vi- ral myocarditis with obvious effect, less adverse reactions, it is worthy of clinical application.
出处
《中国现代医生》
2013年第1期125-126,共2页
China Modern Doctor
关键词
病毒性心肌炎
诊治效果
预后
Diagnosis and treatment of viral myocarditis
Effect
Prognosis
